D

Taysha Gene Therapies, Inc. TSHA

NASDAQ
Recommendation
Dividend Power Score
Day's Range
$3.97$4.18
Latest Close
Volume
--
Avg Vol (90D)
Market Cap
Dividend & Yield
--
P/E (TTM)
--
EPS (TTM)
My Lists My Alerts

09/30/2026 06/30/2026 03/31/2026 12/31/2025 09/30/2025
Revenue -- -- -- 171.27% --
Total Other Revenue -- -- -- -- --
Total Revenue -- -- -- 171.27% --
Cost of Revenue -- -- -- -- --
Gross Profit -- -- -- 171.27% --
SG&A Expenses 58.30% 41.27% 18.62% 33.25% 4.77%
Depreciation & Amortization -- -- -- -- --
Other Operating Expenses -- -- -- -- --
Total Operating Expenses 23.07% 76.70% 83.31% 53.89% 48.91%
Operating Income -23.07% -89.82% -103.01% -41.98% -61.56%
Income Before Tax -19.54% -73.50% -96.99% -48.26% -28.24%
Income Tax Expenses -- -- -- -- --
Earnings from Continuing Operations -19.54% -73.50% -96.99% -48.26% -28.24%
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -- -- -- -- --
Net Income -19.54% -73.50% -96.99% -48.26% -28.24%
EBIT -23.07% -89.82% -103.01% -41.98% -61.56%
EBITDA -23.35% -90.70% -104.33% -42.66% -62.47%
EPS Basic -4.00% -40.13% -44.81% -11.29% 2.83%
Normalized Basic EPS -5.98% -54.22% -50.43% -7.76% -24.60%
EPS Diluted -4.00% -40.13% -44.81% -11.29% 2.83%
Normalized Diluted EPS -5.98% -54.22% -50.43% -7.76% -24.60%
Average Basic Shares Outstanding 14.94% 23.84% 36.14% 33.14% 31.92%
Average Diluted Shares Outstanding 14.94% 23.84% 36.14% 33.14% 31.92%
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --